Wed, 22 Jan 2020 16:44:43: NICE shuts out AstraZeneca's Tagrisso—and dings J&J's Stelara, too

Wed, 22 Jan 2020 15:31:53: Fighting for market share, J&J expects last year's copycat pain to 'bleed into 2020'

Wed, 22 Jan 2020 15:21:27: Lonza's next CEO to be pharma or biotech vet, chairman says

Wed, 22 Jan 2020 15:00:05: 'Pharmaceutical dystopia': Former Insys exec decries sexist hiring in sentencing memo

Tue, 21 Jan 2020 23:08:30: FDA study asks whether drug names change how consumers, docs view meds

Tue, 21 Jan 2020 21:53:26: Moderna, federal researchers kick off vaccine work against deadly new coronavirus

Tue, 21 Jan 2020 21:10:19: Horizon notches blockbuster FDA approval for rare eye disease med Tepezza

Tue, 21 Jan 2020 19:18:36: As pipeline fattens, Lilly commits $470M for new plant with 460 jobs

Tue, 21 Jan 2020 15:05:20: GlaxoSmithKline halts Excedrin production over manufacturing stumble

Tue, 21 Jan 2020 15:03:31: JPM: Merck turns to contract manufacturers to help with Gardasil supply, plans 2023 plant openings

Tue, 21 Jan 2020 15:01:56: JPM: Gilead leans on data, focus to launch filgotinib into jam-packed RA market

Tue, 21 Jan 2020 14:42:19: An SGLT2 windfall? Heart failure gold rush likely to benefit diabetes players: analyst

Tue, 21 Jan 2020 14:22:09: Roche's digital partnerships flourish under live-and-let-live approach

Fri, 17 Jan 2020 19:58:41: Allergan highlights strong women in new Botox ads for chronic migraine use

Fri, 17 Jan 2020 15:16:45: Novo's Ozempic scores major win with heart-helping FDA approval. Is Rybelsus next?

Fri, 17 Jan 2020 13:54:26: Hengrui's Sun Piaoyang, China's richest pharma leader, steps down after 30-year run—sort of

Fri, 17 Jan 2020 09:36:03: FiercePharmaAsia—Astellas' cell therapy deal; Takeda's €398M tax bill; Lilly-shared PD-1 in NSCLC

Thu, 16 Jan 2020 19:44:31: JPM sound bites, vol. 1: Couch shopping, cool drones and 'smelling the turkey'

Thu, 16 Jan 2020 17:13:32: Think JPM seemed slow this year? You're not alone—and here's why

Thu, 16 Jan 2020 15:34:33: Celltrion CEO says China is next move on its game board for biosimilar production: report

Thu, 16 Jan 2020 15:32:31: JPM: Glaxo sees enormous Shingrix potential, but a supply gap still stands in the way

Thu, 16 Jan 2020 14:55:54: JPM: With Vascepa's U.S. expansion rolling, Amarin CEO holds off partner offers in EU

Thu, 16 Jan 2020 14:43:29: WuXi Biologics taking over Bayer plant, giving it a jump on its global expansion plans

Wed, 15 Jan 2020 16:42:23: Celgene taps Bristol-Myers sales force to bolster key blood cancer launches

Wed, 15 Jan 2020 15:52:06: FDA wrath falls on Chinese OTC maker of children's drugs